Evaluation and Management of Urethritis in a 30-Year-Old Male
This 30-year-old male with dysuria, burning on urination, urethral itching, and low back pain for 2 weeks most likely has urethritis and should be tested for both N. gonorrhoeae and C. trachomatis using nucleic acid amplification tests (NAATs), then treated empirically with dual therapy covering both pathogens while awaiting results.
Diagnostic Approach
Initial Testing
The clinical presentation—dysuria, burning, urethral itching—is classic for urethritis 1. Perform urinalysis and obtain specimens for NAAT testing for both gonorrhea and chlamydia, as these are the two principal bacterial pathogens in men with urethritis 1. NAATs are more sensitive than traditional culture techniques for C. trachomatis and are the preferred detection method 1.
If you have access to microscopy and Gram stain, examine urethral discharge or first-void urine. The diagnosis of urethritis is confirmed if you find:
- Urethral discharge visible on examination
- Positive leukocyte esterase on first-void urine
- ≥10 white blood cells per high-power field in urine sediment 2
Distinguishing Gonococcal from Nongonococcal Urethritis
If Gram-negative intracellular diplococci are identified on urethral smear, this indicates gonococcal urethritis. If absent, diagnose nongonococcal urethritis (NGU) 1. C. trachomatis causes 15-55% of NGU cases 1.
The Low Back Pain Component
The low back pain warrants attention. In the context of urethritis symptoms, consider:
- Epididymitis: A known complication of C. trachomatis infection 1
- Prostatitis: More common in men over 35, but possible at age 30 3
- Examine for testicular tenderness, epididymal swelling, or prostatic tenderness on physical examination
Treatment Strategy
Empiric Dual Therapy
If diagnostic tools are unavailable or while awaiting test results, treat empirically for both gonorrhea and chlamydia 1. The CDC guidelines emphasize that testing to determine specific etiology is recommended because both infections are reportable, and specific diagnosis enhances partner notification and treatment compliance 1.
First-line empiric therapy combines:
- Azithromycin or doxycycline (for chlamydia/NGU) PLUS
- Ceftriaxone or cefixime (for gonorrhea) 2
This dual approach is considered first-line empiric therapy in patients with urethritis 2.
Important Caveats
Partner management is critical: Both the patient and sexual partners need treatment. Expedited partner treatment (giving prescriptions for partners who haven't been examined) is advocated by the CDC and approved in many states 2.
If symptoms persist after initial treatment: Consider testing for Mycoplasma genitalium, which has been implicated in NGU cases 1, 4. Recent evidence suggests that persistent urethritis or cervicitis with negative initial testing warrants M. genitalium testing 4.
Why Not Just Treat Empirically Without Testing?
While empiric treatment is appropriate initially, specific diagnosis is important because:
- Both infections are reportable to health departments 1
- Specific diagnosis improves partner notification 1
- Documentation of chlamydia is important given complications like epididymitis and Reiter's syndrome 1
- Virtual encounters without laboratory testing may increase recurrent symptoms and antibiotic courses 4
Follow-Up Considerations
If symptoms persist after appropriate treatment, further workup should include:
- Testing for atypical organisms (M. genitalium, Ureaplasma urealyticum) 1, 4
- Consider Trichomonas vaginalis and HSV if clinically indicated 1
- Re-evaluate for complications (epididymitis, prostatitis)
- Consider noninfectious causes if all infectious workup is negative 4, 5
The combination of specific testing plus empiric dual therapy optimizes outcomes by treating immediately while confirming the diagnosis for public health reporting and partner management.